A consortium of 28 laboratories to observe genomic variations in coronavirus has beneficial the centre to contemplate COVID-19 booster dose for individuals who are 40 years and older amid the specter of Omicron, a brand new variant of concern. India has reported two circumstances of Omicron an infection.
“Vaccination of all remaining unvaccinated at-risk folks and consideration of a booster dose for these 40 years of age and over, first concentrating on essentially the most high-risk and high-exposure could also be thought-about, since low ranges of neutralising antibodies from present vaccines are unlikely to be ample to neutralise Omicron, though threat of extreme illness continues to be more likely to be decreased,” INSACOG stated in its weekly bulletin.
Quick for Indian SARS-CoV-2 Genomics Consortium, INSACOG checks variations in coronavirus throughout the nation to assist perceive the way it spreads and evolves, and recommend the very best public well being response.
“Genomic surveillance will likely be essential for early detection of the presence of this variant (Omicron) to allow crucial public well being measures. Monitoring journey to and from identified affected areas, and contact-tracing of COVID-19 circumstances with an epidemiological hyperlink to the affected areas has been carried out together with elevated testing (with sequencing of confirmed circumstances),” the consortium stated in its bulletin.